25th Feb 2026 TASUKI-52 study of combination therapy using nivolumab, platinum chemotherapy, and bevacizumab for advanced or recurrent nonsquamous NSCLC: a plain language summary
22nd Jan 2026 HARMONi-2 trial results comparing two treatments for PD-L1–positive non-small cell lung cancer: a plain language summary
